Valneva Reports Positive Phase 1 Results for Secon...
Category : Clinical Trial Update 6 November 2025October 2025 – Saint-Herblain, France: Valneva SE, a specialty vaccine company, has reported p...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Cipla to Acquire 100% Stake in Inzpera Healthscien...
Category : Merger/Acquisition 6 November 2025Mumbai, November 3, 2025: Pharmaceutical major Cipla Limited has entered into a definitive agreement...
FDA Grants Orphan Drug Designation to Calico and A...
Category : ODD/BTA/FTA Status 6 November 2025California, October 2025: Calico Life Sciences LLC (Calico), a biotechnology company founded by Alph...
Ascletis Showcases Promising Data from Obesity Dru...
Category : Clinical Trial Update 5 November 2025ASC30 oral tablet achieves up to 6.5% placebo-adjusted weight reduction; injectable formulation demo...
MetaVia Presents Positive Phase 1 and Preclinical...
Category : Clinical Trial Update 5 November 2025DA-1726 demonstrates favorable safety, dose-proportional pharmacokinetics, and meaningful weight los...
Latest Newsletter Post
-
FDA Grants Orphan Drug Designation..
6 November 2025
-
Cipla to Acquire 100% Stake in Inzp..
6 November 2025
-
Valneva Reports Positive Phase 1 Re..
6 November 2025
-
Spinogenix Reports Positive Phase 2..
5 November 2025
-
MetaVia Presents Positive Phase 1 a..
5 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com